EORTC 1617-QLG-BCG
Research type
Research Study
Full title
Follow-up in Early and Locally Advanced Breast Cancer\nPatients
IRAS ID
268985
Contact name
Galina Velikova
Contact email
Sponsor organisation
EORTC (European Organisation for the Research and Treatment of Cancer)
Duration of Study in the UK
1 years, 11 months, 31 days
Research summary
This study is for patients with early or locally advanced breast cancer who have already had their primary treatment. \n\nThe objective of this study is to identify patients who have more physical and/or psychosocial problems after treatment for breast cancer. It will also assess the current follow-up patterns in the UK compared with other European countries.\n\nPatients will be invited to complete one set of patient reported questionnaires (a total of 5 questionnaires consisting of a maximum 139 questions) whilst attending the hospital for a routine visit or if no longer having a routine follow up, will be contacted by an ethically approved invite letter.\n\nThe questionnaires will assess the patient’s quality of life as well as their satisfaction with the follow-up service that they have received. \n\nThis study will take place in NHS sites in the UK as part of a wider international study. \n\nThe study is sponsored and coordinated by the EORTC (European Organisation for Research and Treatment of Cancer), a non-profit organisation\nbased in Brussels.\n\n\n
REC name
Yorkshire & The Humber - Leeds West Research Ethics Committee
REC reference
20/YH/0023
Date of REC Opinion
20 Jan 2020
REC opinion
Favourable Opinion